知Yizhi Daily
← Back to this edition

World

China’s Multiple Departments Strengthen Supply Safeguards for Shortage Drugs

Edition 2026-11-11 · 08:00 Beijing time

According to the National Health Commission website, the national and provincial consultation and coordination mechanisms for ensuring the supply of shortage drugs have recently strengthened interdepartmental coordination and information sharing. Relevant departments have taken measures concerning shortage information monitoring, supply guarantees for cyclophosphamide for injection, stockpiling of flood-prevention medicines, and the resumption of production of primaquine phosphate tablets.

According to China News Network, citing the National Health Commission website, in the recent period, member units of the national and provincial consultation and coordination mechanisms for ensuring the supply of shortage drugs have strengthened interdepartmental coordination and information sharing to improve capacity for guaranteeing supplies of shortage drugs.

In terms of monitoring and response, the National Health Commission has guided local authorities in verifying and responding to information about drug shortages and regularly notified members of the national coordination mechanism and local authorities about monitoring and handling developments. The Ministry of Industry and Information Technology has dynamically monitored, analyzed, and issued early warnings on the production and supply of clinically necessary drugs prone to shortages; the National Healthcare Security Administration has continued monitoring the prices and distribution of shortage drugs; and the National Medical Products Administration has carried out basic information marking and data updates for shortage drugs, collecting production and supply information and production suspension reports.

In response to insufficient supply of cyclophosphamide for injection, the National Health Commission launched a national response and worked with multiple departments to study safeguard measures. The Ministry of Industry and Information Technology established a weekly scheduling mechanism to promote existing domestic cyclophosphamide manufacturers to increase production capacity in an orderly manner; the National Healthcare Security Administration guided local authorities in completing online listing of cyclophosphamide for injection produced by domestic enterprises.

To ensure the public’s medication needs, the Ministry of Commerce also guided key distribution enterprises to strengthen flood-prevention supply guarantees and make preparations for stockpiling key medicines and emergency drills. Multiple departments also coordinated and organized the resumption of production of the antimalarial drug primaquine phosphate tablets.

Original sources

中新网国内 ↗
Back to this editionOpen interactive reader